Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney

Clinical trial NCT02613819 · UNKNOWN

Trial details

NCT number: NCT02613819
Sponsor: Trans Tasman Radiation Oncology Group
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma

Start date: 2016-07-01
Primary completion: 2025-04-01
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.